Intermediate Dose Dabigatran for Atrial Fibrillation


    loading  Checking for direct PDF access through Ovid

Abstract

SOURCE:Eikelboom JW, et al. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: An analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial. Circulation 2011;123:2363–2372.

    loading  Loading Related Articles